Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glatiramer Acetate in PLWHIV with Poor Immune Recovery
NCT07851337Phase 2Not yet recruiting
- Sponsor
- ANRS
- Start
- Dec 2026
- Primary completion
- Dec 2028
01
Overview
A Phase 2 trial of glatiramer acetate in human immunodeficiency virus infection (HIV), sponsored by ANRS. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
glatiramer acetate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT07851337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07851337.